Dynavax Technologies | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
AbbVie USD 700M 90M 2025-03
Adma Biologics USD 2.88M 620K 2024-12
Amgen USD 694M 29M 2025-06
AstraZeneca 303M 126M 2025-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.68M 184K 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Dynavax Technologies USD 1.69M 12K 2025-03
Gilead Sciences USD 260M 12M 2025-03
Glaxosmithkline 178.05M 24.73M 2024-12
Merck USD 305M 8M 2025-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 289M 19M 2025-06
Pfizer USD 654M 0 2025-06
Regeneron Pharmaceuticals USD 3.6M 5.1M 2025-06
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 5.23M 725K 2025-06
TG Therapeutics USD 6.72M 4.12M 2025-06
Vertex Pharmaceuticals USD 3.7M 900K 2025-06


Dynavax Technologies Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.